Article Details

FDA approves oral version of Mitsubishi's ALS drug | BioPharma Dive

Retrieved on: 2022-05-13 17:06:39

Tags for this article:

Click the tags to see associated articles and topics

FDA approves oral version of Mitsubishi's ALS drug | BioPharma Dive. View article details on hiswai:

Excerpt

Merit Cudkowicz, director of the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital, told BioPharma Dive last year that about ...

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up